论文部分内容阅读
目的:探讨前房型人工晶体植入术后并发症的治疗方法及效果。方法:回顾性分析我院2004年6月至2010年6月收治的前房型人工晶体植入术后大疱性角膜病变患者22例(32眼)的临床资料,该组患者均采取人工晶体摘除和角膜羊膜植入术治疗,总结该组患者的临床疗效。结果:术后患者的眼部刺激症状、结膜大泡均消失,房水清,眼压和视力显著优于术前,P<0.05。随访6个月～2年,无复发患者出现。结论:角膜羊膜植入术是治疗前房型人工晶体植入术后大疱性角膜病变较为安全、可靠的方法。
Objective: To explore the treatment of anterior chamber intraocular lens implantation complications and the results. Methods: The clinical data of 22 patients (32 eyes) with bullous keratopathy after anterior chamber intraocular lens implantation in our hospital from June 2004 to June 2010 were retrospectively analyzed. The patients were treated with artificial lens ablation And corneal amniotic membrane implantation, summarizes the clinical efficacy of this group of patients. Results: The symptoms of eye irritation and conjunctival bullae disappeared, the aqueous humor, intraocular pressure and visual acuity were significantly better than those before operation (P <0.05). Follow-up 6 months to 2 years, no recurrence of patients. Conclusion: Amniotic membrane implantation is a safe and reliable method for the treatment of bullous keratopathy after anterior chamber intraocular lens implantation.